Hydroxyurea Capsule bulk supplier for pharma manufacturers

Hydroxyurea Capsule 500 mg, 1000 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 500 mg, 1000 mg

Reference Brands: Droxia(US); Hydrea(US & EU)

Hydroxyurea inhibits DNA synthesis by blocking ribonucleotide reductase, reducing proliferation of abnormal cells. It increases fetal hemoglobin production, alleviating sickle cell symptoms, and reduces tumor growth in certain cancers. Benefits include improved quality of life, fewer sickling crises, and enhanced disease management in sickle cell anemia and specific malignancies.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Hydroxyurea capsules, marketed as Hydrea and Hydroxycarbamide, are approved by the FDA in the US and EMA in the EU for sickle cell anemia and certain cancers. Regulatory approval requires a detailed dossier including clinical trial data, manufacturing standards, safety, efficacy, and pharmacovigilance plans. In the US, submission to the FDA involves comprehensive review processes, while the EU mandates adherence to regional quality and safety guidelines. For expert guidance on dossier preparation, regulatory pathways, and successful market entry strategies, visit PharmaTradz. Ensuring compliance with regional regulations is crucial for the approval, safe use, and global commercialization of hydroxyurea capsules.

Hydroxyurea Capsule — third party manufacturing & bulk supply

Hydroxyurea Capsule 500 mg, 1000 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Hydroxyurea Capsule is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Hydroxyurea Capsule listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Hydroxyurea Capsule →

Back to Listing

Frequently Asked Questions

Hydroxyurea Capsule is listed as Capsules in 500 mg, 1000 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Hydroxyurea Capsule is referenced against Droxia(US); Hydrea(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.